Pharma channel feed – Endpoints News

Pharma channel feed

European regulators recommend rejection of Merck’s Covid-19 drug molnupiravir

3 years ago

Pfizer's Paxlovid gets March FDA advisory meeting to discuss full approval

3 years ago

GSK's bellwether Zantac court date pushed to July

3 years ago

AstraZeneca pulls back the corporate curtain to highlight real people and chat complex science

3 years ago

Rocket Pharma re-ups rare disease awareness with Empire State Building light-up

3 years ago

Pharma tips majority ad spending to digital media for first time, research finds

3 years ago

Roche and Blueprint agree to end collaboration for cancer drug Gavreto

3 years ago

Ex-Phlow exec, cousin arrested in Kodak insider trading scheme

3 years ago

Bristol Myers, Boehringer and Roche top Ogilvy Health’s latest social media rankings

3 years ago

Bristol Myers expands footprint in India with drug development and IT center

3 years ago

Moderna predicts $5B in 2023 Covid vaccine sales, reports net income loss and cost increases

3 years ago

Democrats petition US patent office to probe Merck's new Keytruda requests

3 years ago

CMS not ready to reconsider its block on covering new Alzheimer's drugs

3 years ago

Amneal Pharmaceuticals site in India receives 483 over cleaning and other quality issues

3 years ago

FDA approves Sanofi's factor VIII hemophilia A drug

3 years ago

Pfizer cuts CRO unicorn from Lyme vaccine trial in dispute over conduct

3 years ago

Capsida and AbbVie make $70M upfront deal for genetic medicines in eye diseases

3 years ago

J&J to impose new limits on 340B access after industry court win

3 years ago

Pfizer says RSV shot to protect infants may be available by 2023-24 cold and flu season

3 years ago

Boehringer Ingelheim broadcasts third podcast season around rare lung condition

3 years ago

Charles River handed subpoena by DOJ over non-human primate supply

3 years ago

UK initiates review of clinical trials after decreases in recruitment, number of studies

3 years ago

PharmaEssentia takes Besremi rare blood cancer message to consumers

3 years ago

BioNTech touts differences with Moderna in race for cancer vaccines

3 years ago

First page Previous page 143 144 145146147 148 149 Next page Last page